|
¼ò½é
ÈËÀàʳÓôóËâ(Garlic)¼ºÓкܳ¤µÄÀúÊ·¡£ÏÖ´úÑо¿¼º¾·¢ÏÖÁË´óËâµÄ¶àÖÖ±£¼ü×÷Óã¬
°üÀ¨Î¬»¤ÐÄѪ¹Ü¡¢ÐÄÔàµÄ½¡¿µÒÔ¼°½µµÍµ¨¹Ì´¼Ë®Æ½¡£† È»¶øºÜ¶àÈË¿ÉÄܲ»ÖªµÀ´óËâµÄÕâЩºÃ´¦´ó¶à¶ªÊ§ÔÚ´óËâÈÕ³£Åë⿹ý³ÌÖС£
Ö»Óо¹ýÌØ±ð´¦ÀíºóµÄ´óË⾫²ÅÄÜÆðµ½ÕæÕý±£¼üµÄ×÷Óá£
|
|
±£½¡¹¦Ð§
ÃÀ¹úºÍŷѵµÄÑо¿ÈËÔ±½øÐÐÁË´óÁ¿ÁÙ´²ÊÔÑéÒÔÆÀ¹À´óË⾫ÓÃÒÔ¿ØÖƵ¨¹Ì´¼µÄÒ½ÁÆÐ§¹û¡£¾
×ۺϷÖÎö13ÆðËæ»ú£¬¶ÔÕÕ¼°Ë«Ã¤ÊÔÑéµÄ½á¹û£¬·¢ÏÖÆäÖÐ10ÆðÊÔÑé±íÃ÷´óË⾫ºÍ¿Õ°×¶ÔÕÕÏà±ÈÄÜÏÔÖøµØ½µµÍ×ܵ¨¹Ì´¼Ë®Æ½¡£
Èç¹û°ÑÊ®ÈýÏîÊÔÑé½á¹û×Ü»ãºóͳһ·ÖÎö£¬·þÓÃÌ«Ë⾫µÄ²ÎÓëÕßµÄ×ܵ¨¹Ì´¼Ë®Æ½ÓÐÃ÷ÏÔµÄϽµ£ºÆ½¾ùϽµµÄ·ù¶ÈΪ15.7 mg/dL
(Ò»°ãÈÏΪ×ܵ¨¹Ì´¼Ë®Æ½³¬¹ý200 mg/dL¼´Îª¸ßµ¨¹Ì´¼) ¡£ÔÚͬһ·ÖÎö±¨¸æÖУ¬Ñо¿ÈËÔ±·¢ÏÖ´óË⾫²¢Î´ÄÜÏÔÖø½µµÍµÍÃܶȵ¨
¹Ì´¼Ë®Æ½¼°Ôö¼Ó¸ßÃܶȵ¨¹Ì´¼Ë®Æ½¡£1
ºÍ´¦·½Ò©Lipitor Ïà±È, ´óË⾫½µµÍ×ܵ¨¹Ì´¼Ë®Æ½µÄЧ¹û±È½Ï»ººÍ¡£È»¶øÕýÊÇÕâÖÖκ͵Ä×÷ÓúÍËüµÄ°²È«ÐÔ(¼ûÏÂ)£¬
ÒÔ¼°µÍÁ®µÄ¼Û¸ñʹ´óË⾫³ÉΪ¹ã´óÏû·ÑÕßÈÕ³£ÓÃÓÚά³Öµ¨¹Ì´¼ÔÚ½¡¿µË®Æ½µÄÀíÏë±£½¡Ê³Æ·¡£
|
|
»îÐԳɷÖ
Ñо¿±íÃ÷´óËâ³É·ÝÖÐÓÐÒæ½¡¿µµÄ³É·ÝΪ´óËâËØ(allicin)¡£´óËâËØÔÚÐÂÏÊËâÍ·Öк¬Á¿ºÜÉÙ¡£ÔÚʳÓÃ×¼±¸¹ý³ÌÖе±´óËâ±»ÅÄËé¼°½Ó´¥Ë®ºó£¬
ÆäÖеÄø°Ñalliinת»¯¶ø²úÉú³ö¸ü¶àµÄ´óËâËØ£¬²¢É¢·¢ÆäÌØÓÐÐÁÀ±Ëâζ¡£´óËâËØºÜÈÝÒ׷ֽ⣬Òò´Ëͨ³£µÄ´óËâÅëâ¿ÎÞ·¨±£Áô´óËâËØµÄ»îÐÔ´Ó¶ø²»Äܳä·Ö·¢»ÓËüµÄ±£½¡¹¦Ð§¡£
ÐÂÏÊ´óËâ¿ÉÒÔ¾¹ýÌØ±ð´¦ÀíºóÖÆ³É¸ÉÔï·Û䣬ÔÙÖÆ³ÉƬ¼Á¶ø±ÜÃâalliin±»×ª»¯³É´óËâËØ¡£ÕâЩƬ¼Á»¹¿ÉÔÙÍâ¼Ó°üÒÂÒÔÈ·±£´óËâËØÖ»ÔÚС³¦ÄÚ²úÉú¶ø²»ÔÚ¿ÚÇ»ÄÚ²úÉú¡£
´Ó¶øÈ·±£´óËâËØÄܱ»Ð¡³¦Ö±½ÓÎüÊÕ¶ø·¢»ÓÆä¹¦Ð§²¢ÇÒ±ÜÃâÔÚ¿ÚÇ»ÄÚ²úÉúÒìζ¡£
ÕâÑù´¦ÀíºóµÄ´óË⾫ÕýÊÇÑо¿ÈËÔ±ÔÚÑо¿ÊÔÑéÖÐʹÓõıê×¼»¯µÄ´óËâÌáÈ¡Îï¡£±ê×¼ÌáÈ¡Îï´ÓÐÂÏÊ´óËâ°êÖо3±¶Å¨Ëõºó£¬Ëùº¬´óËâËØÍ¨³£ÔÚ1%×óÓÒ¡£
|
|
¼ÁÁ¿ºÍÁƳÌ
ÔÚ´óË⾫µÄÁÙ´²ÊÔÑéÖУ¬²ÎÓëÊÔÑéÕßͨ³£Ã¿ÈÕ·þÓÃ540ÖÁ1340ºÁ¿ËµÄ´óË⾫¡£ÕâÖÖ¼ÁÁ¿´óÖ²úÉú4ÖÁ10ºÁ¿ËµÄ´óËâËØ¡£×î³£ÓüÁÁ¿Îª800»ò900ºÁ¿Ë¡£Èç¹ûÿÈÕËù·þ´óË⾫²úÉúµÄ´óËâËØÔÚ4ºÁ¿ËÒÔÏ£¬Õâ¸ö¼ÁÁ¿Ò»°ã±»ÈÏΪÊDz»¹»µÄ¡£ÊÔÑéÕß·þÓôóË⾫µÄʱ¼ä³ÖÐøÈýÖÁÁù¸öÔ¡£
|
|
¸±×÷ÓÃ
´óË⾫ÔÚÁÙ´²ÊÔÑéÖм¸ºõûÓи±×÷Ó㬶øÇÒ·¢ÉúÂʲ¢²»¸ßÓÚ¿Õ°×°²Î¿¼ÁµÄ¶ÔÕÕ×é¡£1ֻżÓб¨µÀÇá¶ÈµÄ賦µÀ²»ÊÊ¡£
|
|
Ò©ÎïµÄÏ໥×÷ÓÃ
Óб¨µÀÌáʾ´óËâÓпÉÄÜºÍÆäËü´¦·½Ò©Îï, Èç½µµÍѪҺճ¶ÈÒ©ÎïwarfarinºÍ¿¹°®×̲¡Ò©saquinavir, ²úÉúÏ໥×÷Óá£ËùÒÔÓ¦¸ÃСÐÄËüÓëijЩҩÎïµÄÏ໥×÷Óá£
|
|
²Î¿¼ÎÄÏ×
1. Stevinson C, Pittler MH, Ernst
E. Garlic for treating hypercholesterolemia. A meta-analysis
of randomized clinical trials. Ann Intern Med. 2000 Sep
19;133(6):420-9.
by X. Li, Ph. D. (credential)
±¾ÄÚÈÝÊÜ֪ʶ²úȨ·¨Âɱ£»¤£¬ÈçÓÐÇÖº¦½«×·Ëß·¨ÂÉÔðÈΡ£
|